相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis
Safaa Al-Thamiree Mezban et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2023)
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Richard Cunningham et al.
CLINICAL SCIENCE (2022)
The two sides of Hippo pathway in cancer
Fu-Long Li et al.
SEMINARS IN CANCER BIOLOGY (2022)
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Shenghong Ma et al.
NATURE COMMUNICATIONS (2022)
The Signaling Pathways Associated With Breast Cancer Bone Metastasis
Xuelian Song et al.
FRONTIERS IN ONCOLOGY (2022)
The Hippo signalling pathway and its implications in human health and diseases
Minyang Fu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review
Anastasios Kyriazoglou et al.
BREAST CARE (2021)
The lingering mysteries of metastatic recurrence in breast cancer
Alessandra I. Riggio et al.
BRITISH JOURNAL OF CANCER (2021)
HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway
Jianxin Xu et al.
CANCER BIOLOGY & THERAPY (2021)
BONEMETASTASIS: MECHANISMS, THERAPIES, AND BIOMARKERS
Philippe Clezardin et al.
PHYSIOLOGICAL REVIEWS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hippo signalling maintains ER expression and ER+ breast cancer growth
Shenghong Ma et al.
NATURE (2021)
Novel approaches to target the microenvironment of bone metastasis
Lorenz C. Hofbauer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma
Lin Li et al.
CELL DEATH & DISEASE (2021)
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Konstantinos Venetis et al.
CELLS (2021)
Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach
He Shen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells
Xinxin Yuan et al.
THERANOSTICS (2021)
Murine Placental-Fetal Phosphate Dyshomeostasis Caused by an Xpr1 Deficiency Accelerates Placental Calcification and Restricts Fetal Growth in Late Gestation
Bongjun Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
Xiaoqiu Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
Heinrich Kovar et al.
CELLS (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway
Yifan Wang et al.
CELL DEATH & DISEASE (2020)
Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
Lea Monteran et al.
SCIENTIFIC REPORTS (2020)
Editorial: Quality of Life in Breast Cancer Patients and Survivors
Marco Invernizzi et al.
FRONTIERS IN ONCOLOGY (2020)
Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals
Panpan An et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P
Boon-Shing Tan et al.
ONCOGENE (2019)
IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis
Mengmeng Liang et al.
CELL DEATH & DISEASE (2019)
Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization
Wei Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Bone Metastasis of Breast Cancer
Rie K. Tahara et al.
BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION (2019)
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
Rohini K. Hernandez et al.
BMC CANCER (2018)
The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation
Jinhu Xiong et al.
BONE (2018)
Breast cancer bone metastases: pathogenesis and therapeutic targets
Naomi Brook et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
The emerging role of Hippo signaling pathway in regulating osteoclast formation
Wanlei Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The role of Hippo signal pathway in breast cancer metastasis
Changran Wei et al.
ONCOTARGETS AND THERAPY (2018)
Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy-Induced Neutropenia in Breast Cancer Patients
Behzad Bidadi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Bone metastasis pattern in initial metastatic breast cancer: a population-based study
Zhenchong Xiong et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The Osteoclast in Bone Metastasis: Player and Target
Antonio Maurizi et al.
CANCERS (2018)
Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1 /FAK signalling in breast cancer
Jie Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Understanding the Bone in Cancer Metastasis
Jaime Fornetti et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
Lanqing Cao et al.
HUMAN PATHOLOGY (2017)
YAP1 negatively regulates chondrocyte differentiation partly by activating the β-catenin signaling pathway
Beining Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
A ROR1 HER3 IncRNA signalling axis modulates the Hippo YAP pathway to regulate bone metastasis
Chunlai Li et al.
NATURE CELL BIOLOGY (2017)
Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway
Chuanzhen Hu et al.
ONCOTARGET (2017)
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
Jie Liu et al.
SCIENTIFIC REPORTS (2017)
Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation
Yi Tang et al.
CELL CYCLE (2017)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Implications of Hypoxia in Breast Cancer Metastasis to Bone
Daniele M. Gilkes
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation
Yi Tang et al.
NATURE CELL BIOLOGY (2016)
ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling
Jun Wang et al.
SCIENCE SIGNALING (2016)
ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling
Jun Wang et al.
SCIENCE SIGNALING (2016)
CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG
Eriko Aoyama et al.
BONE (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
被撤回的出版物: Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma (Retracted article. See vol. 393, 2020)
Paola Maroni et al.
EXPERIMENTAL CELL RESEARCH (2015)
YAP/TAZ for cancer therapy: Opportunities and challenges
Liwen Guo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation
Jongwon Lee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Lisha Xiang et al.
ONCOTARGET (2015)
Impact of skeletal-related events on survival in patients with metastatic prostate cancer prescribed androgen deprivation therapy
KW Wong et al.
HONG KONG MEDICAL JOURNAL (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation
M. R. Byun et al.
CELL DEATH AND DIFFERENTIATION (2014)
Genetics of breast cancer bone metastasis: a sequential multistep pattern
Hassan Fazilaty et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells
Samantha E. Hiemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
Zhongyuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment
Yongshun Lin et al.
NATURE COMMUNICATIONS (2014)
The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression
Laura M. Koontz et al.
DEVELOPMENTAL CELL (2013)
TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis
Dong Zhao et al.
CARCINOGENESIS (2012)
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Wenjun Guo et al.
CELL (2012)
TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin
Nuo Yang et al.
CELL CYCLE (2012)
Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice
Hoogeun Song et al.
EMBO JOURNAL (2012)
New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation
Fengyan Jin et al.
MOLECULAR CANCER RESEARCH (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
Dahu Chen et al.
NATURE MEDICINE (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
CCN Family 2/Connective Tissue Growth Factor (CCN2/CTGF) Promotes Osteoclastogenesis via Induction of and Interaction with Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)
Takashi Nishida et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice
Dominic P. Del Re et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways
F. E. Lock et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Examining the Metastatic Niche: Targeting the Microenvironment
Theresa Guise
SEMINARS IN ONCOLOGY (2010)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
The LIM protein, LIMD1, regulates AP-1 activation through an interaction with TRAF6 to influence osteoclast development
Yunfeng Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer
Tsuyoshi Shimo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
